Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroya Takeuchi

Showing results (181-190 of 482) with videos related to

Pageof 49
Sort By:
Inflammatory Bowel Diseases|December 6, 2018
Tenascin-C Produced by Intestinal Myofibroblasts Promotes Colitis-associated Cancer Development Through AngiogenesisTakafumi Kawamura, Masayoshi Yamamoto, Katsunori Suzuki, et al.
Plos One|September 16, 2014
Antitumor effect of the tyrosine kinase inhibitor nilotinib on gastrointestinal stromal tumor (GIST) and imatinib-resistant GIST cellsHiroyuki Sako, Kazumasa Fukuda, Yoshiro Saikawa, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|July 27, 2017
Optimal minimally invasive surgical procedure for gastric submucosal tumorsYoshiaki Shoji, Hiroya Takeuchi, Osamu Goto, et al.
Medicine|June 17, 2016
Clinical outcome of transthoracic esophagectomy with thoracic duct resection: Number of dissected lymph node and distribution of lymph node metastasis around the thoracic ductSatoru Matsuda, Hiroya Takeuchi, Hirofumi Kawakubo, et al.
Annals of Surgical Oncology|June 18, 2021
ASO Author Reflections: Response to Neoadjuvant Chemotherapy Strengthens the Prognostic Impact of Pathological Stage for Esophageal Squamous Cell CarcinomaSatoru Matsuda, Hirofumi Kawakubo, Akihiko Okamura, et al.
Anticancer Research|January 31, 2021
IL-8/CXCR2 Signalling Promotes Cell Proliferation in Oesophageal Squamous Cell Carcinoma and Correlates With Poor PrognosisMasazumi Inoue, Hiroya Takeuchi, Sachiko Matsuda, et al.
General Thoracic and Cardiovascular Surgery|February 27, 2014
Optimal surgical management for esophagogastric junction carcinomaTatsuo Matsuda, Hiroya Takeuchi, Shinichi Tsuwano, et al.
Radiation Oncology (London, England)|January 9, 2014
Phase I study of neoadjuvant chemoradiotherapy with S-1 plus biweekly cisplatin for advanced gastric cancer patients with lymph node metastasis: -KOGC04-Satoru Matsuda, Tsunehiro Takahashi, Junichi Fukada, et al.
Annals of Surgical Oncology|June 22, 2014
Cumulative prognostic scores based on plasma fibrinogen and serum albumin levels in esophageal cancer patients treated with transthoracic esophagectomy: comparison with the Glasgow prognostic scoreSatoru Matsuda, Hiroya Takeuchi, Hirofumi Kawakubo, et al.
Esophagus : Official Journal of the Japan Esophageal Society|February 13, 2026
Can combined organ resection cure T4 esophageal cancer? Insights from a multi-institutional study of incomplete resection casesAkihiko Okamura, Masayuki Watanabe, Jun Okui, et al.
Pageof 49

Showing results (181-190 of 482) with videos related to

Sort By:
Pageof 49
Inflammatory Bowel Diseases|December 6, 2018
Tenascin-C Produced by Intestinal Myofibroblasts Promotes Colitis-associated Cancer Development Through AngiogenesisTakafumi Kawamura, Masayoshi Yamamoto, Katsunori Suzuki, et al.
Plos One|September 16, 2014
Antitumor effect of the tyrosine kinase inhibitor nilotinib on gastrointestinal stromal tumor (GIST) and imatinib-resistant GIST cellsHiroyuki Sako, Kazumasa Fukuda, Yoshiro Saikawa, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|July 27, 2017
Optimal minimally invasive surgical procedure for gastric submucosal tumorsYoshiaki Shoji, Hiroya Takeuchi, Osamu Goto, et al.
Medicine|June 17, 2016
Clinical outcome of transthoracic esophagectomy with thoracic duct resection: Number of dissected lymph node and distribution of lymph node metastasis around the thoracic ductSatoru Matsuda, Hiroya Takeuchi, Hirofumi Kawakubo, et al.
Annals of Surgical Oncology|June 18, 2021
ASO Author Reflections: Response to Neoadjuvant Chemotherapy Strengthens the Prognostic Impact of Pathological Stage for Esophageal Squamous Cell CarcinomaSatoru Matsuda, Hirofumi Kawakubo, Akihiko Okamura, et al.
Anticancer Research|January 31, 2021
IL-8/CXCR2 Signalling Promotes Cell Proliferation in Oesophageal Squamous Cell Carcinoma and Correlates With Poor PrognosisMasazumi Inoue, Hiroya Takeuchi, Sachiko Matsuda, et al.
General Thoracic and Cardiovascular Surgery|February 27, 2014
Optimal surgical management for esophagogastric junction carcinomaTatsuo Matsuda, Hiroya Takeuchi, Shinichi Tsuwano, et al.
Radiation Oncology (London, England)|January 9, 2014
Phase I study of neoadjuvant chemoradiotherapy with S-1 plus biweekly cisplatin for advanced gastric cancer patients with lymph node metastasis: -KOGC04-Satoru Matsuda, Tsunehiro Takahashi, Junichi Fukada, et al.
Annals of Surgical Oncology|June 22, 2014
Cumulative prognostic scores based on plasma fibrinogen and serum albumin levels in esophageal cancer patients treated with transthoracic esophagectomy: comparison with the Glasgow prognostic scoreSatoru Matsuda, Hiroya Takeuchi, Hirofumi Kawakubo, et al.
Esophagus : Official Journal of the Japan Esophageal Society|February 13, 2026
Can combined organ resection cure T4 esophageal cancer? Insights from a multi-institutional study of incomplete resection casesAkihiko Okamura, Masayuki Watanabe, Jun Okui, et al.
Pageof 49